Atlas Trials

Lenalidomide/Low-dose Dexamethasone in Combination With Continuous Oral Cyclophosphamide Compared to Lenalidomide/Low-dose Dexamethasone Combined With Single Cyclophosphamide Doses IV in Patients With Relapsed/Refractory Multiple Myeloma

Clinical trial NCT01019174 · COMPLETED

Trial details

NCT number
NCT01019174
Sponsor
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2009-11-01
Primary completion
2013-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.